activity
20162023
most citedModel-based Recursive Partitioning for Subgroup Analyses

170 citations · 433 across the 10 of their papers we have counts for

collaborators

10 papers

stat.CO2023★ 6 cited

Improving Software Engineering in Biostatistics: Challenges and Opportunities

Daniel Sabanés Bové, Heidi Seibold, Anne-Laure Boulesteix +9

Programming is ubiquitous in applied biostatistics; adopting software engineering skills will help biostatisticians do a better job. To explain this, we start by highlighting key c…

stat.ME2022★ 6 cited

What Makes Forest-Based Heterogeneous Treatment Effect Estimators Work?

Susanne Dandl, Torsten Hothorn, Heidi Seibold +3

Estimation of heterogeneous treatment effects (HTE) is of prime importance in many disciplines, ranging from personalized medicine to economics among many others. Random forests ha…

cs.GL2020★ 40 cited

An Environment for Sustainable Research Software in Germany and Beyond: Current State, Open Challenges, and Call for Action

Hartwig Anzt, Felix Bach, Stephan Druskat +40

Research software has become a central asset in academic research. It optimizes existing and enables new research methods, implements and embeds research knowledge, and constitutes…

cs.SE2019★ 47 cited

Open Science in Software Engineering

Daniel Méndez Fernández, Daniel Graziotin, Stefan Wagner +1

Open science describes the movement of making any research artefact available to the public and includes, but is not limited to, open access, open data, and open source. While open…

stat.ME2019★ 13 cited

Survival Forests under Test: Impact of the Proportional Hazards Assumption on Prognostic and Predictive Forests for ALS Survival

Natalia Korepanova, Heidi Seibold, Verena Steffen +1

We investigate the effect of the proportional hazards assumption on prognostic and predictive models of the survival time of patients suffering from amyotrophic lateral sclerosis (…

stat.ME2018★ 19 cited

Subgroup identification in dose-finding trials via model-based recursive partitioning

Marius Thomas, Björn Bornkamp, Heidi Seibold

An important task in early phase drug development is to identify patients, which respond better or worse to an experimental treatment. While a variety of different subgroup identif…

stat.ML2017★ 43 cited

OpenML: An R Package to Connect to the Machine Learning Platform OpenML

Giuseppe Casalicchio, Jakob Bossek, Michel Lang +6

OpenML is an online machine learning platform where researchers can easily share data, machine learning tasks and experiments as well as organize them online to work and collaborat…

stat.CO2016★ 30 cited

Generalised Linear Model Trees with Global Additive Effects

Heidi Seibold, Torsten Hothorn, Achim Zeileis

Model-based trees are used to find subgroups in data which differ with respect to model parameters. In some applications it is natural to keep some parameters fixed globally for al…

stat.ME2016★ 170 cited

Model-based Recursive Partitioning for Subgroup Analyses

Heidi Seibold, Achim Zeileis, Torsten Hothorn

The identification of patient subgroups with differential treatment effects is the first step towards individualised treatments. A current draft guideline by the EMA discusses pote…

stat.ME2016★ 59 cited

Individual Treatment Effect Prediction for ALS Patients

Heidi Seibold, Achim Zeileis, Torsten Hothorn

A treatment for a complicated disease may be helpful for some but not all patients, which makes predicting the treatment effect for new patients important yet challenging. Here we…